BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 17979153)

  • 1. VEGF in biological control.
    Breen EC
    J Cell Biochem; 2007 Dec; 102(6):1358-67. PubMed ID: 17979153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ; Ellis LM
    J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor.
    Ferrara N
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):789-91. PubMed ID: 19164810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
    Takahashi H; Shibuya M
    Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights on the biology and clinical aspects of VEGF regulation.
    Birk DM; Barbato J; Mureebe L; Chaer RA
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) signaling in tumor progression.
    Roskoski R
    Crit Rev Oncol Hematol; 2007 Jun; 62(3):179-213. PubMed ID: 17324579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular endothelial growth factor--structure and functions].
    Barańska P; Jerczyńska H; Pawłowska Z
    Postepy Biochem; 2005; 51(1):12-21. PubMed ID: 16209337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the differential activation of vascular endothelial growth factor (VEGF) receptors.
    Horta BA; Sodero AC; de Alencastro RB
    J Mol Graph Model; 2009 Oct; 28(3):287-96. PubMed ID: 19734078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of vascular endothelial growth factors.
    Tammela T; Enholm B; Alitalo K; Paavonen K
    Cardiovasc Res; 2005 Feb; 65(3):550-63. PubMed ID: 15664381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF) in physiological and pathological conditions.
    Chodorowska G; Chodorowski J; Wysokiński A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):8-14. PubMed ID: 16146041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of angiogenesis in the primate endometrium: vascular endothelial growth factor.
    Chennazhi KP; Nayak NR
    Semin Reprod Med; 2009 Jan; 27(1):80-9. PubMed ID: 19197807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of VEGF signalling output by the Notch pathway.
    Siekmann AF; Covassin L; Lawson ND
    Bioessays; 2008 Apr; 30(4):303-13. PubMed ID: 18348190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury.
    Lahm T; Crisostomo PR; Markel TA; Wang M; Lillemoe KD; Meldrum DR
    Shock; 2007 Jul; 28(1):4-14. PubMed ID: 17510598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.
    Ribatti D
    Br J Haematol; 2005 Feb; 128(3):303-9. PubMed ID: 15667531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.